What is ventricular bigeminy?
Emojis in electronic health records could be confusing
Doing different types of exercise linked to a longer life
CPR on TV may be misleading
How gum disease may raise heart disease risk
FDA approves nasal spray to treat rapid heart rhythm
Smart watch may improve detection of atrial fibrillation
Understanding food noise - and how to turn down the volume
4 keys to a heart-healthy diet
Understanding exercise heart rate zones
Medical Tests & Procedures Archive
Articles
Is it safe to stop aspirin a year after a stent?
After a heart attack or stent placement, people typically take a combination of aspirin and another antiplatelet drug. After one year, the new standard practice is to stop the aspirin, in contrast to the previous practice of stopping the other drug.
Let's not call it cancer
Roughly one in six men will be diagnosed with prostate cancer at some point in their lives, but these cancers usually aren't life-threatening. The least risky form of the disease occurs frequently with age, will not metastasize to other parts of the body, and it doesn't require any immediate treatment. So, should it even be called cancer?
A liquid biopsy for metastatic prostate cancer
Researchers are developing tools for predicting how fast prostate cancer might progress; among the most promising are those that count circulating tumor cells (CTCs) in blood samples. Research shows that high CTC counts predict poorer survival and faster disease progression. But they are also predictive for early-stage metastatic prostate cancer that still responds to hormonal therapy.
Transperineal prostate biopsies linked with lower infection risk
In a 2024 study, transperineal prostate biopsies were less likely to cause infections than traditional transrectal biopsies. Transperineal biopsies retrieve tissue samples using a thin needle inserted through the skin between the scrotum and rectum.
Pap smears or self-swabs?
Pap tests, the mainstay screening method to detect cervical cancer, are uncomfortable for some women. In mid-2024, the FDA approved a new self-swab test that can detect human papillomavirus, which causes most cases of cervical cancer. The self-swab test collects cells from the vaginal wall instead of the cervix. Clinicians guide women on how to perform the test in a doctor's office. The self-swab method offers women several benefits, including comfort, accuracy, and potentially greater access to screening.
Could imaging scans replace biopsies during prostate cancer screening?
Abnormal results on a prostate-specific antigen (PSA) screening test for cancer are typically followed by a systematic biopsy. But systematic biopsies can be problematic, and researchers are seeking alternatives. A large European study provides encouraging evidence favoring a different approach that uses MRI instead of biopsy.
What is ventricular bigeminy?
Emojis in electronic health records could be confusing
Doing different types of exercise linked to a longer life
CPR on TV may be misleading
How gum disease may raise heart disease risk
FDA approves nasal spray to treat rapid heart rhythm
Smart watch may improve detection of atrial fibrillation
Understanding food noise - and how to turn down the volume
4 keys to a heart-healthy diet
Understanding exercise heart rate zones
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up